RENASYS DYNAFLOW Kit (66807741)
Smith & Nephew Medical, Ltd. · Decision date Sep 11, 2026
What did the FDA decide?
FDA's 510(k) record K261338 covers the RENASYS DYNAFLOW Kit (66807741), filed by Smith & Nephew Medical, Ltd. of Hull, GB, and classified as a Negative Pressure Wound Therapy Powered Suction Pump under 21 CFR 878.4780, product code OMP, in the General & Plastic Surgery specialty. The application was received 04/23/2026 and decided 09/11/2026 as Substantially Equivalent (SESE), a clearance to market rather than a PMA approval.
The record describes a Traditional 510(k) that was not reviewed by a third party, was not a combination product, and had no authorized Predetermined Change Control Plan. The specific components, materials or design changes distinguishing this kit from its predicate device are not stated in the available record, and the summary document itself was not retrieved. No clinical, efficacy or labeling conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261338
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Smith & Nephew Medical, Ltd.
- Product code
- OMP
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Negative Pressure Wound Therapy Powered Suction Pump.
- Applicant
- Smith & Nephew Medical, Ltd.
- Product code
- OMP
- FDA device class
- 2
FDA decision timeline
K261338 received
Application receipt date recorded by FDA.
K261338 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OMP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bechtel Medical, Inc. | 510(k) clearance | Nov 6, 2026 | FDA | |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Oct 23, 2026 | FDA | |
MeCare Alpha (MCA2019)K260426 | IVT Medical, Ltd. | 510(k) clearance | Oct 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Smith & Nephew Medical, Ltd.
- Headquarters
- Not reported
- Brand website
- smith-nephew.com
- FDA applicant address
- Hull
Sources and methodology
- Original FDA record: K261338
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


